About Smith & Nephew plc
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. Its knee systems include LEGION/GENESIS II Total Knee System and JOURNEY II Family of Active Knees. Its hip systems include the ANTHOLOGY Hip System, SYNERGY Hip System, the SMF Femoral Hip System, POLARSTEM Femoral Hip System, the R3 Acetabular System and the POLARCUP Dual Mobility Hip System. Its Sports Medicine Joint Repair products include the FAST-FIX family of meniscal repair systems, the ENDOBUTTON family for knee ligament reconstruction, HEALICOIL PK, FOOTPRINT PK and TWINFIX Suture anchors for repairs of the hip and rotator cuff.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: LON
- Symbol: SN
- Previous Close: $15.03
- 50 Day Moving Average: $1204.38
- 200 Day Moving Average: $1199.72
- 52-Week Range: GBX 1,064.91 - GBX 1,324
- Trailing P/E Ratio: 13.74
- P/E Growth: 2.93
- Market Cap: $10.68B
- Outstanding Shares: 885,795,000
Consensus Ratings for Smith & Nephew plc (LON:SN) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||9 Hold Ratings, 4 Buy Ratings|
|Consensus Rating:||Hold (Score: 2.31)|
|Consensus Price Target: ||GBX 1,292.08|
Analysts' Ratings History for Smith & Nephew plc (LON:SN)
(Data available from 2/25/2015 forward)
|2/15/2017||Berenberg Bank||Lower Price Target||Hold||GBX 1,340 -> GBX 1,275|
|2/13/2017||Deutsche Bank AG||Boost Price Target||Hold||GBX 1,150 -> GBX 1,200|
|2/12/2017||J P Morgan Chase & Co||Reiterated Rating||Neutral||GBX 1,260|
|2/10/2017||Morgan Stanley||Reiterated Rating||Overweight||GBX 1,301|
|2/10/2017||Jefferies Group LLC||Lower Price Target||Buy||GBX 1,370 -> GBX 1,350|
|2/9/2017||Numis Securities Ltd||Reiterated Rating||Add||GBX 1,350|
|2/8/2017||Credit Suisse Group||Reiterated Rating||Neutral||GBX 1,190|
|11/25/2016||Goldman Sachs Group, Inc. (The)||Lower Price Target||Buy||GBX 1,370 -> GBX 1,310|
|8/10/2016||Barclays PLC||Downgrade||Equal weight||GBX 1,230 -> GBX 1,240|
|8/9/2016||Beaufort Securities||Reiterated Rating||Hold|
|7/29/2016||BNP Paribas||Reiterated Rating||Outperform||GBX 1,425|
|3/17/2016||Nomura||Initiated Coverage||Neutral||GBX 1,215|
|3/10/2016||AlphaValue||Reiterated Rating||Add||GBX 1,389|
|2/9/2016||Sanford C. Bernstein||Reiterated Rating||Outperform||GBX 1,340|
|4/30/2015||Shore Capital||Reiterated Rating||Sell|
|4/30/2015||Investec||Reiterated Rating||Hold||GBX 1,216|
Earnings History for Smith & Nephew plc (LON:SN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Smith & Nephew plc (LON:SN)
Current Year EPS Consensus Estimate: $0.86 EPS
Dividend History for Smith & Nephew plc (LON:SN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Smith & Nephew plc (LON:SN)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/15/2016||Bottomley ,Virginia||Insider||Buy||238||GBX 1,290||£3,070.20|
|5/11/2016||Bottomley ,Virginia||Insider||Buy||8||GBX 1,158||GBX 9,264|
|8/14/2015||Barlow ,Ian||Insider||Buy||153||GBX 1,188||£1,817.64|
|5/13/2015||Vinita Bali||Insider||Buy||2,400||GBX 1,118||£26,832|
|3/9/2015||Julie Brown||Insider||Sell||4,227||GBX 1,128.79||£47,713.95|
|2/5/2015||Julie Brown||Insider||Sell||11,789||GBX 1,181||£139,228.09|
Latest Headlines for Smith & Nephew plc (LON:SN)
What is Smith & Nephew plc's stock symbol?
Smith & Nephew plc trades on the London Stock Exchange (LON) under the ticker symbol "SN."
Where is Smith & Nephew plc's stock going? Where will Smith & Nephew plc's stock price be in 2017?
13 equities research analysts have issued 1 year target prices for Smith & Nephew plc's stock. Their forecasts range from GBX 1,190 to GBX 1,425. On average, they anticipate Smith & Nephew plc's stock price to reach GBX 1,292.08 in the next year.
When will Smith & Nephew plc announce their earnings?
Smith & Nephew plc is scheduled to release their next quarterly earnings announcement on Thursday, February, 9th 2017.
How do I buy Smith & Nephew plc stock?
Shares of Smith & Nephew plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Smith & Nephew plc stock cost?
One share of Smith & Nephew plc stock can currently be purchased for approximately GBX 1,206.